
Joseph Moore Pelham
Examiner (ID: 14289, Phone: (571)272-4786 , Office: P/3742 )
| Most Active Art Unit | 3742 |
| Art Unit(s) | 3761, 3742, 2106 |
| Total Applications | 2549 |
| Issued Applications | 1998 |
| Pending Applications | 99 |
| Abandoned Applications | 463 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16855227
[patent_doc_number] => 20210155972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => TARGETED RARE ALLELE CRISPR ENRICHMENT
[patent_app_type] => utility
[patent_app_number] => 17/102855
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102855
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102855 | TARGETED RARE ALLELE CRISPR ENRICHMENT | Nov 23, 2020 | Abandoned |
Array
(
[id] => 16933771
[patent_doc_number] => 20210199660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => BIOMARKERS OF BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/100106
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100106
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/100106 | BIOMARKERS OF BREAST CANCER | Nov 19, 2020 | Abandoned |
Array
(
[id] => 18058429
[patent_doc_number] => 20220389515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => USE OF BIOMARKERS TO PREDICT CLINICAL SENSITIVITY TO 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/772101
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772101
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772101 | USE OF BIOMARKERS TO PREDICT CLINICAL SENSITIVITY TO 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE | Oct 26, 2020 | Abandoned |
Array
(
[id] => 16629019
[patent_doc_number] => 20210047672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => METHODS FOR DIAGNOSING BACTERIAL VAGINOSIS
[patent_app_type] => utility
[patent_app_number] => 17/079617
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079617
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/079617 | Methods for diagnosing bacterial vaginosis | Oct 25, 2020 | Issued |
Array
(
[id] => 16992252
[patent_doc_number] => 20210230672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHOD FOR THE DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
[patent_app_type] => utility
[patent_app_number] => 17/067524
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17067524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/067524 | METHOD FOR THE DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS | Oct 8, 2020 | Abandoned |
Array
(
[id] => 16886758
[patent_doc_number] => 20210172954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => DIAGNOSTIC AND PROGNOSTIC MARKER FOR PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/035318
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17035318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/035318 | DIAGNOSTIC AND PROGNOSTIC MARKER FOR PROSTATE CANCER | Sep 27, 2020 | Abandoned |
Array
(
[id] => 16720491
[patent_doc_number] => 20210087638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => NEXT-GENERATION SEQUENCING ASSAY FOR GENOMIC CHARACTERIZATION AND MINIMAL RESIDUAL DISEASE DETECTION IN THE BONE MARROW, PERIPHERAL BLOOD, AND URINE OF MULTIPLE MYELOMA AND SMOLDERING MYELOMA PATIENTS
[patent_app_type] => utility
[patent_app_number] => 17/029684
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17029684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/029684 | NEXT-GENERATION SEQUENCING ASSAY FOR GENOMIC CHARACTERIZATION AND MINIMAL RESIDUAL DISEASE DETECTION IN THE BONE MARROW, PERIPHERAL BLOOD, AND URINE OF MULTIPLE MYELOMA AND SMOLDERING MYELOMA PATIENTS | Sep 22, 2020 | Pending |
Array
(
[id] => 17946188
[patent_doc_number] => 20220333205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => NON-INVASIVE METHOD FOR THE DIAGNOSIS OR SCREENING OF COLORECTAL CANCER AND/OR PRE-CANCEROUS STAGE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/625547
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625547 | NON-INVASIVE METHOD FOR THE DIAGNOSIS OR SCREENING OF COLORECTAL CANCER AND/OR PRE-CANCEROUS STAGE THEREOF | Jul 13, 2020 | Pending |
Array
(
[id] => 17828387
[patent_doc_number] => 20220265691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => METHODS FOR USE OF GENE EXPRESSION AS AN INDICATOR OF E-SELECTIN INHIBITOR EFFICACY AND CLINICAL OUTCOME FOR MULTIPLE TUMOR TYPES
[patent_app_type] => utility
[patent_app_number] => 17/626399
[patent_app_country] => US
[patent_app_date] => 2020-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626399
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626399 | METHODS FOR USE OF GENE EXPRESSION AS AN INDICATOR OF E-SELECTIN INHIBITOR EFFICACY AND CLINICAL OUTCOME FOR MULTIPLE TUMOR TYPES | Jul 11, 2020 | Abandoned |
Array
(
[id] => 17913619
[patent_doc_number] => 20220316014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => METHODS FOR DIAGNOSING THE EFFECTIVENESS OF ANTI-TUMOR TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/624829
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624829 | METHODS FOR DIAGNOSING THE EFFECTIVENESS OF ANTI-TUMOR TREATMENT | Jul 5, 2020 | Pending |
Array
(
[id] => 20466826
[patent_doc_number] => 12522859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-13
[patent_title] => Method and kit for detecting target nucleic acid fragment
[patent_app_type] => utility
[patent_app_number] => 17/620868
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 34
[patent_no_of_words] => 4142
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620868 | Method and kit for detecting target nucleic acid fragment | Jul 5, 2020 | Issued |
Array
(
[id] => 16557558
[patent_doc_number] => 20210002706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Methods For Determining Antimicrobial Drug Resistance
[patent_app_type] => utility
[patent_app_number] => 16/920109
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16920109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/920109 | Methods For Determining Antimicrobial Drug Resistance | Jul 1, 2020 | Abandoned |
Array
(
[id] => 18170365
[patent_doc_number] => 20230036976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => POLYMORPHISMS AS PREDICTORS OF TREATMENT RESPONSE AND OVERALL SURVIVAL OF METASTATIC COLORECTAL CANCER
[patent_app_type] => utility
[patent_app_number] => 17/620573
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620573 | POLYMORPHISMS AS PREDICTORS OF TREATMENT RESPONSE AND OVERALL SURVIVAL OF METASTATIC COLORECTAL CANCER | Jun 18, 2020 | Pending |
Array
(
[id] => 16571081
[patent_doc_number] => 20210010087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => Systems And Methods For Treating Patients Having A Genetic Predisposition To Develop Prostate Cancer
[patent_app_type] => utility
[patent_app_number] => 16/902552
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902552
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902552 | Systems And Methods For Treating Patients Having A Genetic Predisposition To Develop Prostate Cancer | Jun 15, 2020 | Pending |
Array
(
[id] => 16312738
[patent_doc_number] => 20200291476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => ASSAY FOR PRE-OPERATIVE PREDICTION OF ORGAN FUNCTION RECOVERY
[patent_app_type] => utility
[patent_app_number] => 16/888447
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888447
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888447 | Assay for pre-operative prediction of organ function recovery | May 28, 2020 | Issued |
Array
(
[id] => 17749993
[patent_doc_number] => 20220228198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => METHOD FOR MULTIPLEXED DETECTION OF NUCLEIC ACIDS USING SPECTRALLY ENCODED BEADS
[patent_app_type] => utility
[patent_app_number] => 17/613676
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/613676 | METHOD FOR MULTIPLEXED DETECTION OF NUCLEIC ACIDS USING SPECTRALLY ENCODED BEADS | May 26, 2020 | Pending |
Array
(
[id] => 16452985
[patent_doc_number] => 20200362411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => METHOD FOR PREDICTING CERVICAL SHORTENING AND PRETERM BIRTH
[patent_app_type] => utility
[patent_app_number] => 16/880766
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880766
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/880766 | Method for predicting cervical shortening and preterm birth | May 20, 2020 | Issued |
Array
(
[id] => 16452995
[patent_doc_number] => 20200362421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => CLASSIFICATION AND ACTIONABILITY INDICES FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/863360
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863360 | CLASSIFICATION AND ACTIONABILITY INDICES FOR CANCER | Apr 29, 2020 | Pending |
Array
(
[id] => 16361450
[patent_doc_number] => 20200318201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => METHODS OF DETECTING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/853027
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853027 | Methods of detecting prostate cancer | Apr 19, 2020 | Issued |
Array
(
[id] => 16238678
[patent_doc_number] => 20200255912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => TET2 as a Diagnostic and Pronostic Marker in Hematopoietic Neoplasms
[patent_app_type] => utility
[patent_app_number] => 16/843507
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843507
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843507 | TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms | Apr 7, 2020 | Issued |